Recombinant Neisseria meningitidis serogroup B Probable ubiquinone biosynthesis protein UbiB (ubiB)

Shipped with Ice Packs
In Stock

Description

Introduction to UbiB in Neisseria meningitidis

The ubiB gene encodes a protein involved in ubiquinone biosynthesis, a critical pathway for bacterial energy production and membrane stability. While ubiB is well-characterized in some pathogens, its role in Neisseria meningitidis serogroup B remains poorly understood due to limited experimental data. This article synthesizes available information on ubiB and contextualizes its potential significance within meningococcal biology.

Mechanistic Insights into Ubiquinone Biosynthesis

Ubiquinone (coenzyme Q) is essential for electron transport and oxidative phosphorylation. The ubiB protein is implicated in the hydroxylation of 2-octaprenylphenol to 2-octaprenyl-6-hydroxyphenol, a key step in ubiquinone synthesis. This process is conserved across Gram-negative bacteria, including Neisseria spp.

Table 1: Key Steps in Bacterial Ubiquinone Biosynthesis

StepEnzyme/ProteinFunction
1UbiAConverts chorismate to 4-hydroxybenzoate (4-HB)
2UbiC/UbiECatalyzes prenylation of 4-HB to form polyprenyl-4-HB
3UbiBHydroxylates 2-octaprenylphenol to 2-octaprenyl-6-hydroxyphenol
4UbiDMethylates intermediates to form demethoxyubiquinone
5UbiXReduces intermediates to complete ubiquinone synthesis

Adapted from computational predictions in N. meningitidis hypothetical protein studies .

Key Observations from Related Neisserial Proteins

  • TbpA/TbpB: Iron-acquisition proteins critical for meningococcal survival under iron-limited conditions .

  • PorB: Serogroup B porin protein with vaccine potential, eliciting bactericidal antibodies .

  • fHBP: Factor H-binding protein that inhibits complement and serves as a vaccine target .

Research Gaps and Future Directions

The absence of direct studies on ubiB in N. meningitidis highlights critical gaps:

  1. Functional Validation: No data confirm ubiB’s enzymatic activity or localization in N. meningitidis.

  2. Pathogenic Role: Whether ubiB contributes to iron acquisition, oxidative stress resistance, or host immune evasion remains speculative.

  3. Vaccine Potential: Unlike fHBP or PorB, ubiB’s surface exposure and antigenicity are unexplored .

Table 2: Comparative Analysis of Neisserial Vaccine Candidates

ProteinFunctionVaccine PotentialBactericidal Activity
TbpATransferrin bindingLimited (conformation-dependent antibodies)Low
TbpBTransferrin bindingModerate (strain-specific protection)High
PorBPorin channelSerogroup B-specificHigh
fHBPComplement evasionBroad protection (subfamily-based vaccines)High
ubiBUbiquinone biosynthesisUnknownN/A

Data sourced from experimental studies on meningococcal proteins .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ubiB; NMB0559; Probable protein kinase UbiB; Ubiquinone biosynthesis protein UbiB
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-503
Protein Length
full length protein
Species
Neisseria meningitidis serogroup B (strain MC58)
Target Names
ubiB
Target Protein Sequence
MKWLKRLTVIVGTFYRYRLAGLCASLMGSGWICALLKMMPQSSKLKNEPPAVRLRLALES LGPIFIKFGQVLSTRPDLIPHDYAVELAKLQDKVPPFDARLSREQIEKSLGQSIEKLYAE FETEPIASASIAQVHKARLHSGEQVAVKVLRPNLLPVIEQDLSLMRFGAGWVERLFADGK RLKPREVVAEFDKYLHDELDLMREAANASQLGRNFQNSDMLIVPKVFYDYCTSDVLTIEW MDGTPVSDIAKLKADGIDLHKLADYGVEIFFTQVFRDGFFHADMHPGNILVAADNRYIAL DFGIVGTLTDYDKRYLAINFLAFFNRDYRRVATAHIESGWVPADTRAEELEAAVRAVCEP VFNKPISQISFGLVLMRLFEVSRRFNVEIQPQLVLLQKTLLNIEGLGRQLDPDLDLWKTA KPFLVKWMNGQVGPKALWRNLKNEAPDWAQIIPSLPRKISALIDENRQQEMRDAYIHLVK VQQRQSLWLAVIAVVLLLILLLK
Uniprot No.

Target Background

Function
This protein is likely a protein kinase regulator of UbiI activity, involved in aerobic coenzyme Q (ubiquinone) biosynthesis.
Database Links

KEGG: nme:NMB0559

STRING: 122586.NMB0559

Protein Families
ABC1 family, UbiB subfamily
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the biological significance of ubiquinone biosynthesis in Neisseria meningitidis virulence?

Ubiquinone (UQ) plays a critical role in bacterial metabolism as an essential component of the respiratory chain. In proteobacteria, UQ biosynthesis pathways contribute to optimizing bacterial metabolism across varying oxygen conditions, which is particularly relevant for pathogens like N. meningitidis that encounter different oxygen environments during infection . The O2-independent ubiquinone biosynthesis pathway enables bacteria to synthesize ubiquinone in the absence of O2, likely contributing to the adaptability of pathogens in oxygen-limited environments. This metabolic flexibility has been linked to antibiotic resistance, virulence, and the capacity to develop in complex host environments .

To investigate this relationship methodologically:

  • Generate knockout mutants of ubiquinone biosynthesis genes using techniques similar to those described for other N. meningitidis genes

  • Evaluate growth characteristics under aerobic and anaerobic conditions

  • Assess virulence in mouse models of infection, such as the intracisternal challenge model

  • Quantify bacterial survival in different tissues following infection

What experimental models are suitable for studying UbiB function in N. meningitidis?

Based on established methodologies for N. meningitidis research, several experimental models can be adapted to study UbiB function:

In vitro models:

  • Recombinant protein expression in E. coli, as demonstrated for other N. meningitidis proteins

  • Affinity chromatography for protein purification, utilizing protein binding properties

  • Genetic manipulation techniques including gene inactivation by single crossover, as described for other N. meningitidis genes

In vivo models:

  • Mouse intraperitoneal-infection model, which has been used to evaluate other N. meningitidis proteins

  • Intracisternal injection model in BALB/c mice, which allows for assessment of bacterial replication in the brain and other organs

For gene function studies, researchers typically:

  • Construct knockout mutants using Neisseria-E. coli shuttle plasmids

  • Transform N. meningitidis with plasmid DNA

  • Confirm successful gene inactivation through Southern blot hybridization

  • Assess virulence through survival studies in mouse models

  • Monitor bacterial load in different organs (brain, spleen, and liver)

How does oxygen availability affect ubiquinone biosynthesis in bacterial pathogens like N. meningitidis?

Research on ubiquinone biosynthesis in proteobacteria demonstrates the existence of both O2-dependent and O2-independent pathways. According to studies on E. coli, the O2-independent UQ biosynthetic pathway relies on proteins UbiT, UbiU, and UbiV, where UbiU and UbiV form a heterodimer with each protein binding a 4Fe-4S cluster via conserved cysteines that are essential for activity .

N. meningitidis, as a proteobacterium, likely possesses similar mechanisms for adapting to varying oxygen levels. This is particularly important as the bacterium transitions between different host environments during infection, from the oxygen-rich nasopharynx to potentially oxygen-limited sites during invasive disease.

Methodologically, researchers investigate oxygen effects by:

  • Culturing bacteria under varying oxygen concentrations

  • Measuring ubiquinone production using chromatographic techniques

  • Analyzing expression of ubiquinone biosynthesis genes under different oxygen conditions

  • Assessing bacterial fitness and virulence under oxygen limitation

The ability to synthesize ubiquinone over the entire O2 range likely contributes to optimizing bacterial metabolism in fluctuating environments .

How do ubiquinone biosynthesis pathways relate to potential vaccine development against N. meningitidis?

While ubiquinone biosynthesis proteins are not currently established vaccine targets, they represent an interesting area for exploration given the challenges in developing effective vaccines against N. meningitidis serogroup B.

Vaccine development for N. meningitidis serogroup B has faced unique challenges due to the poor immunogenicity of its capsular polysaccharide and its similarity to human neural cell adhesion molecules, raising concerns about autoimmunity . This has led researchers to focus on protein-based vaccine strategies.

Current protein-based vaccines for serogroup B include:

  • OMV-based vaccines expressing PorA

  • 4CMenB vaccine containing factor H binding protein (fHbp), neisserial adhesin A (NadA), and Neisseria heparin binding antigen (NHBA)

To evaluate new protein targets for vaccines, researchers typically:

  • Assess conservation across diverse strains

  • Determine surface accessibility of the protein

  • Evaluate immunogenicity in animal models using methods similar to those established for TbpA and TbpB

  • Test protective efficacy against challenge with virulent strains

  • Measure bactericidal antibody responses

What are the challenges in expressing and purifying recombinant UbiB from N. meningitidis?

Based on experience with other N. meningitidis proteins, several challenges and solutions can be anticipated for UbiB expression and purification:

Table 1: Challenges and Strategies for Recombinant UbiB Expression

ChallengeMethodological ApproachConsiderations
Expression system selectionE. coli expression systems (as used for TbpA/TbpB) May require optimization of growth conditions and induction parameters
Protein foldingInclusion of chaperones or use of slow induction protocolsCritical for maintaining native conformation
Functional activityRetention of biochemical activity during expressionDemonstrated successfully for TbpA and TbpB, which retained transferrin binding ability
Purification strategyAffinity chromatography based on functional propertiesEffective for N. meningitidis proteins when functional binding is preserved
Protein solubilityFusion tags (His, MBP, GST) to enhance solubilityMembrane-associated proteins often present solubility challenges
Protein stabilityBuffer optimization and addition of stabilizing agentsEssential for downstream structural and functional studies

Additional approaches might include:

  • Codon optimization for expression in E. coli

  • Expression under varying growth conditions to optimize protein yield

  • Assessment of protein functionality through appropriate biochemical assays

How can researchers determine the structure-function relationship of UbiB in N. meningitidis?

Understanding the structure-function relationship of UbiB requires a multidisciplinary approach combining structural analysis with functional characterization:

Structural analysis methods:

  • X-ray crystallography of purified recombinant UbiB

  • Cryo-electron microscopy for protein complexes

  • NMR spectroscopy for dynamic structural information

  • Computational modeling based on homologous proteins

Functional characterization:

  • Site-directed mutagenesis of conserved residues

  • Complementation studies in knockout strains

  • Enzymatic activity assays

  • Protein-protein interaction studies

By integrating structural and functional data, researchers can identify key domains and residues essential for UbiB function. Drawing from research on other ubiquinone biosynthesis proteins like UbiU and UbiV, which form a heterodimer with 4Fe-4S clusters essential for activity , similar functional elements might be explored in UbiB.

Methodological steps should include:

  • Generation of UbiB variants through site-directed mutagenesis

  • Assessment of mutant phenotypes under various growth conditions

  • Comparative analysis with homologous proteins from related species

  • Evaluation of protein-protein interactions through techniques like co-immunoprecipitation

What is the potential role of UbiB in O2-independent ubiquinone biosynthesis pathways?

The identification of O2-independent ubiquinone biosynthesis pathways in proteobacteria involving proteins UbiT, UbiU, and UbiV raises questions about UbiB's potential role in this process. While UbiB is not specifically mentioned in this pathway in the search results, understanding its function would be of significant research interest.

Based on existing knowledge of ubiquinone biosynthesis:

  • UbiU and UbiV form a heterodimer and function as O2-independent hydroxylases with each protein binding a 4Fe-4S cluster

  • The O2-independent pathway enables bacteria to synthesize ubiquinone across the entire O2 range

To investigate UbiB's role methodologically, researchers should:

  • Generate UbiB knockout mutants in N. meningitidis using approaches similar to those described for hrpB

  • Assess growth and ubiquinone production under aerobic and anaerobic conditions

  • Perform complementation studies with UbiB from different bacterial species

  • Conduct comparative genomics to identify conservation of UbiB across species with known O2-independent pathways

  • Investigate potential interactions between UbiB and other ubiquinone biosynthesis proteins

How can researchers evaluate UbiB's contribution to N. meningitidis virulence in infection models?

To investigate UbiB's role in virulence, researchers can adapt methodologies used for other N. meningitidis genes like hrpB :

Generation of UbiB-defective mutants:

  • PCR amplification of UbiB gene fragments using specific primers

  • Cloning into Neisseria-E. coli shuttle plasmids like pDEX

  • Transformation of N. meningitidis and selection with appropriate antibiotics

  • Confirmation of gene inactivation through Southern blot hybridization

Virulence assessment in mouse models:

  • Intracisternal infection model with different bacterial doses (e.g., 10^5-10^7 CFU/mouse)

  • Monitoring survival rates, clinical signs, body weight, and temperature over time

  • Construction of survival curves comparing wild-type and mutant strains (see Figure 1)

Figure 1: Example of survival analysis for wild-type vs. gene knockout strains
(Based on methodologies used for hrpB mutants )

S(t)=eλtS(t) = e^{-\lambda t} where S(t) represents survival probability at time t

Quantitative analysis of bacterial load:

  • Collection of organs (brain, spleen, liver) at different time points post-infection

  • Homogenization and plating for viable count determination

  • Comparison of replication kinetics between wild-type and UbiB-defective strains

These approaches would provide quantitative data on whether UbiB is required for full virulence, similar to observations with other N. meningitidis genes .

What methodologies are most effective for studying protein-protein interactions involving UbiB?

Understanding UbiB's interaction network is crucial for elucidating its function in ubiquinone biosynthesis. Several complementary approaches can be employed:

Table 2: Methodologies for Studying UbiB Protein Interactions

ApproachMethodologyAdvantagesLimitations
In vitro methodsPull-down assays with purified proteinsDirect detection of physical interactionsMay miss weak or transient interactions
Surface plasmon resonanceQuantitative binding kineticsRequires purified proteins
Isothermal titration calorimetryThermodynamic parameters of bindingLow throughput
In vivo methodsBacterial two-hybrid systemsDetects interactions in cellular contextPotential for false positives
Co-immunoprecipitationCaptures native protein complexesRequires specific antibodies
Split-protein complementationCan detect transient interactionsMay affect protein function
Structural approachesX-ray crystallography of complexesAtomic resolution of interaction interfacesCrystallization challenges
Crosslinking mass spectrometryIdentifies interaction regionsTechnical complexity

Of particular interest would be investigating potential interactions between UbiB and proteins known to be involved in the O2-independent ubiquinone biosynthesis pathway, such as UbiT, UbiU, and UbiV .

Methodological considerations include:

  • Expression of tagged versions of UbiB for affinity purification

  • Construction of fusion proteins for two-hybrid experiments

  • Development of specific antibodies for immunoprecipitation studies

  • Optimization of crosslinking conditions to capture transient interactions

What are the implications of UbiB research for developing novel antimicrobial strategies against N. meningitidis?

Targeting ubiquinone biosynthesis represents a potential avenue for antimicrobial development against N. meningitidis:

Metabolic vulnerability:

  • Disruption of ubiquinone biosynthesis could compromise bacterial energy production

  • Particularly effective in oxygen-limited environments encountered during infection

  • May affect multiple aspects of bacterial physiology

Target specificity considerations:

  • The O2-independent ubiquinone biosynthesis pathway is found in multiple proteobacterial clades, including several human pathogens

  • Differences between bacterial and human ubiquinone biosynthesis pathways offer selectivity potential

  • Structural differences in ubiquinone biosynthesis proteins could be exploited for selective targeting

Methodological approach to antimicrobial development:

  • High-throughput screening for small molecule inhibitors of UbiB

  • Structure-based drug design if structural information becomes available

  • Assessment of inhibitor specificity for bacterial versus human homologs

  • Evaluation of antimicrobial efficacy in both aerobic and anaerobic conditions

  • Testing in appropriate infection models for in vivo efficacy

Such research could contribute to addressing the ongoing need for novel antimicrobial strategies against N. meningitidis, particularly for serogroup B strains which remain a significant cause of meningococcal disease in Europe, North America, and Latin America .

What are promising technical advances for studying UbiB function in N. meningitidis?

Several emerging technologies hold promise for advancing UbiB research:

CRISPR-Cas9 genome editing:

  • More precise genetic manipulation than traditional homologous recombination

  • Potential for creating conditional knockdowns to study essential genes

  • Multiplexed targeting for studying genetic interactions

Single-cell technologies:

  • Analysis of gene expression heterogeneity within bacterial populations

  • Tracking protein localization during different growth phases

  • Monitoring metabolic activity at the single-cell level

Systems biology approaches:

  • Integration of transcriptomics, proteomics, and metabolomics data

  • Network analysis to position UbiB within broader metabolic pathways

  • Computational modeling of ubiquinone biosynthesis under varying conditions

Advanced structural biology:

  • Cryo-electron tomography for visualizing proteins in native cellular context

  • Hydrogen-deuterium exchange mass spectrometry for protein dynamics

  • Integrative structural biology combining multiple experimental techniques

Implementing these approaches would provide comprehensive insights into UbiB function and its role in N. meningitidis metabolism and pathogenesis.

How can comparative genomics enhance our understanding of UbiB across bacterial species?

Comparative genomics approaches offer valuable insights into UbiB evolution and function:

Methodological approach:

  • Identification of UbiB homologs across bacterial species

  • Analysis of sequence conservation and divergence

  • Examination of genomic context and gene neighborhoods

  • Correlation with metabolic capabilities and pathogenic potential

Research questions addressable through comparative genomics:

  • Is UbiB conserved across all proteobacteria with O2-independent ubiquinone biosynthesis?

  • Do sequence variations correlate with differences in virulence or metabolic flexibility?

  • Are there species-specific adaptations in UbiB structure or function?

  • Can evolutionary patterns inform potential antimicrobial targeting?

By integrating comparative genomics with experimental approaches, researchers can develop targeted hypotheses about UbiB function and prioritize experimental directions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.